Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Others observations: FIRST CHOICE − High-risk febrile neutropenia − Pyelonephritis or prostatitis (severe) SECOND CHOICE − Sepsis in neonates and children [c] [c]: only for children |
| Peru | 6.2.2.2 Aminoglycosides | No observations |
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| Peru | 6.2.4 Anti-Tuberculosis | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia | 4.0 Anti-Infectious | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
Others observations: Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.. |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
Others observations: Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. |
| Ecuador | Essential Medicines List - Ecuador | No observations |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
| List | Section | Observation |
|---|---|---|
| PAHO Strategic Fund Medicine List | 2.4. Antiberculosis med. 2nd line | No observations |